Immunization Mayo Clinic Vaccines 
Pharmaceutical Technology
APRIL 18, 2023
Within the emerging innovation stage, cell therapy for ocular disorders, coronavirus vaccine components, and DNA polymerase compositions are disruptive technologies that are in the early stages of application and should be tracked closely. These can serve as an important component of a vaccine.
Pharmaceutical Technology
MAY 15, 2023
Its platform has capabilities to be used in combination with CAR-T and other cell therapies to overcome poor immune cell infiltration, immunosuppressive properties of tumour microenvironment, and systematic toxicity issues. The company has an operational presence in the US and the UK (headquartered in Abingdon, Oxfordshire, UK).
Expert insights. Personalized for you.
59 
Let's personalize your content